Amgen puts its KRAS hopes on 'Navy Seals' team of drug hunters - BioPharma Dive

Amgen puts its KRAS hopes on 'Navy Seals' team of drug hunters  BioPharma Dive

Amgen's never moved faster. In late August of last year, the first patient enrolled in a small clinical study received treatment with a cancer drug now known as ...



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked